← All trials
NCT01296542
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- May 31, 2011
- Primary completion
- Jan 31, 2013
- Completion date
- Jan 31, 2013
- First posted
- Feb 15, 2011
- Last posted
- Dec 8, 2020
- Enrollment
- 60
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Bucci Laser Vision InstituteLead sponsor
- Bucci Laser Vision InstituteOverall official - principal investigator
- Bucci Laser Vision InstituteReponsible party - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.